WebDisclosure WebDisclosure
Basculer en Français
9557 Companies
188791 Keywords
120551 Articles
100769 Press releases
Headlines Articles Press releases TRIANA Biomedicines, Inc. Remove
  1. Home
  2. Companies
  3. TRIANA Biomedicines, Inc.
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 10/15/2024 at 14:05, 1 year 2 months ago

    TRIANA Biomedicines Enters Collaboration with Pfizer for Molecular Glue Discovery

    Cancer Treatment Biopharmaceutical Innovation TRIANA Biomedicines Pfizer Collaboration Molecular Glue
  • BRIEF

    published on 10/15/2024 at 14:05, 1 year 2 months ago

    TRIANA Biomedicines conclut un partenariat avec Pfizer pour la découverte d'une colle moléculaire

    Traitement Du Cancer Innovation Biopharmaceutique TRIANA Biomédecines Collaboration Avec Pfizer Colle Moléculaire
  • PRESS RELEASE

    published on 10/15/2024 at 14:00, 1 year 2 months ago

    TRIANA Biomedicines and Pfizer Enter Into A Research Collaboration to Discover Novel Molecular Glue Degraders for Multiple Disease Areas

    TRIANA Biomedicines, Inc. partners with Pfizer for molecular glue discovery, receiving $49 million upfront payment and potential milestones. Collaboration to focus on oncology targets
    Strategic Collaboration Pfizer TRIANA Biomedicines Molecular Glue Discovery Oncology Targets
    Logo of TRIANA Biomedicines, Inc.
Accesswire
  • Published on 12/19/2025 at 18:30, 1 hour 37 minutes ago

    Eagle Plains Shareholders Approve all Matters at Annual General Meeting

  • Published on 12/19/2025 at 14:40, 5 hours 27 minutes ago

    Northern Superior Announces Closing of the Arrangement

  • Published on 12/19/2025 at 13:30, 6 hours 37 minutes ago

    Quartz Commences Trading On The OTCQX Best Market Under The Symbol QZMRF

  • Published on 12/19/2025 at 13:30, 6 hours 37 minutes ago

    DataMetrex Announces Closing of Yuzu Payment Processing Solution Acquisition

  • Published on 12/19/2025 at 13:30, 6 hours 37 minutes ago

    Sterling Metals Provides Year End Update to Stakeholders

View all ACCESSWIRE
EQS Group
  • Published on 12/19/2025 at 19:56, 10 minutes ago

    Original-Research: European Lithium Limited (von First Berlin Equity Research GmbH): Buy

  • Published on 12/19/2025 at 19:00, 1 hour 6 minutes ago

    HIAG sells sites and properties as part of its sharpened corporate strategy and gains Swiss Post as a new tenant in Winterthur

  • Published on 12/19/2025 at 18:29, 1 hour 37 minutes ago

    clearvise AG commissions Triticum agri-photovoltaic project

  • Published on 12/19/2025 at 18:29, 1 hour 37 minutes ago

    Fuller, Smith & Turner PLC: Transaction in own shares

  • Published on 12/19/2025 at 18:27, 1 hour 40 minutes ago

    Resumed Trading in the Bond

View all EQS
Les Echos
  • Published on 12/19/2025 at 08:30, 11 hours 37 minutes ago

    Share capital decrease by way of treasury shares cancellation

  • Published on 12/19/2025 at 08:30, 11 hours 37 minutes ago

    Réduction du capital par voie d’annulation d’actions propres

  • Published on 12/19/2025 at 07:00, 13 hours 7 minutes ago

    EURAZEO ANNONCE AVOIR MENÉ AVEC SUCCÈS UNE TRANSACTION ACCÉLÉRANT SA ROTATION D'ACTIFS

  • Published on 12/19/2025 at 07:00, 13 hours 7 minutes ago

    EURAZEO ANNOUNCES A SUCCESSFUL TRANSACTION ACCELERATING ITS ASSET ROTATION

  • Published on 12/18/2025 at 18:30, 1 day 1 hour ago

    Schneider Electric completes transaction to acquire remaining 35% stake in existing Indian JV

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2025 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy